Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency por Walter Suárez Carmona | Ago 26, 2025
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial por Walter Suárez Carmona | Ago 25, 2025
Novel Dual and Triple Agonists Targeting GLP-1, GIP, Glucagon, and GDF15 for Type 2 Diabetes and Obesity Management por Walter Suárez Carmona | Ago 24, 2025
Effectiveness of whole-body vibration training on body mass reduction: a systematic review and meta-analysis por Walter Suárez Carmona | Ago 24, 2025
Targeting the root cause of obesity-related comorbidities through weight independent and dependent actions on insulin sensitivity: Benefits of dual amylin and calcitonin receptor agonists por Walter Suárez Carmona | Ago 23, 2025
